nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2B6—Thiotepa—sarcoma	0.12	0.158	CbGbCtD
Fluvoxamine—CYP1A1—Dacarbazine—sarcoma	0.0871	0.115	CbGbCtD
Fluvoxamine—CYP2E1—Dacarbazine—sarcoma	0.0673	0.0885	CbGbCtD
Fluvoxamine—CYP2E1—Mitoxantrone—sarcoma	0.0522	0.0687	CbGbCtD
Fluvoxamine—CYP1A2—Dacarbazine—sarcoma	0.0389	0.0512	CbGbCtD
Fluvoxamine—CYP3A7—Vincristine—sarcoma	0.0372	0.0489	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0372	0.0489	CbGbCtD
Fluvoxamine—CYP3A4—Thiotepa—sarcoma	0.0368	0.0484	CbGbCtD
Fluvoxamine—CYP2E1—Etoposide—sarcoma	0.0329	0.0433	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—sarcoma	0.0295	0.0388	CbGbCtD
Fluvoxamine—CYP3A5—Vincristine—sarcoma	0.0279	0.0367	CbGbCtD
Fluvoxamine—ABCB1—Mitoxantrone—sarcoma	0.0264	0.0347	CbGbCtD
Fluvoxamine—CYP3A5—Etoposide—sarcoma	0.0256	0.0336	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—sarcoma	0.0222	0.0291	CbGbCtD
Fluvoxamine—CYP1A2—Etoposide—sarcoma	0.019	0.025	CbGbCtD
Fluvoxamine—ABCB1—Vincristine—sarcoma	0.0182	0.0239	CbGbCtD
Fluvoxamine—ABCB1—Etoposide—sarcoma	0.0167	0.0219	CbGbCtD
Fluvoxamine—CYP3A4—Mitoxantrone—sarcoma	0.0158	0.0208	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—sarcoma	0.0114	0.0149	CbGbCtD
Fluvoxamine—CYP3A4—Vincristine—sarcoma	0.0109	0.0143	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—sarcoma	0.0107	0.0141	CbGbCtD
Fluvoxamine—CYP3A4—Etoposide—sarcoma	0.00998	0.0131	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—sarcoma	0.0068	0.00895	CbGbCtD
Fluvoxamine—Somnolence—Etoposide—sarcoma	0.000152	0.000635	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—sarcoma	0.000152	0.000635	CcSEcCtD
Fluvoxamine—Hypersensitivity—Mitoxantrone—sarcoma	0.000152	0.000633	CcSEcCtD
Fluvoxamine—Asthenia—Vincristine—sarcoma	0.000152	0.000633	CcSEcCtD
Fluvoxamine—Vomiting—Thiotepa—sarcoma	0.000152	0.000633	CcSEcCtD
Fluvoxamine—Pneumonia—Epirubicin—sarcoma	0.000151	0.000632	CcSEcCtD
Fluvoxamine—Drowsiness—Epirubicin—sarcoma	0.00015	0.000628	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—sarcoma	0.00015	0.000628	CcSEcCtD
Fluvoxamine—Rash—Thiotepa—sarcoma	0.00015	0.000627	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—sarcoma	0.00015	0.000627	CcSEcCtD
Fluvoxamine—Dermatitis—Thiotepa—sarcoma	0.00015	0.000627	CcSEcCtD
Fluvoxamine—Headache—Thiotepa—sarcoma	0.000149	0.000623	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000149	0.000623	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—sarcoma	0.000149	0.000623	CcSEcCtD
Fluvoxamine—Decreased appetite—Etoposide—sarcoma	0.000149	0.000621	CcSEcCtD
Fluvoxamine—Renal failure—Epirubicin—sarcoma	0.000148	0.000617	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Etoposide—sarcoma	0.000148	0.000617	CcSEcCtD
Fluvoxamine—Asthenia—Mitoxantrone—sarcoma	0.000148	0.000616	CcSEcCtD
Fluvoxamine—Fatigue—Etoposide—sarcoma	0.000148	0.000616	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Epirubicin—sarcoma	0.000147	0.000616	CcSEcCtD
Fluvoxamine—Stomatitis—Epirubicin—sarcoma	0.000147	0.000612	CcSEcCtD
Fluvoxamine—Jaundice—Epirubicin—sarcoma	0.000147	0.000612	CcSEcCtD
Fluvoxamine—Constipation—Etoposide—sarcoma	0.000146	0.000611	CcSEcCtD
Fluvoxamine—Pain—Etoposide—sarcoma	0.000146	0.000611	CcSEcCtD
Fluvoxamine—Conjunctivitis—Epirubicin—sarcoma	0.000146	0.000611	CcSEcCtD
Fluvoxamine—Urinary tract infection—Epirubicin—sarcoma	0.000146	0.000611	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—sarcoma	0.000146	0.00061	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000145	0.000606	CcSEcCtD
Fluvoxamine—Diarrhoea—Vincristine—sarcoma	0.000145	0.000604	CcSEcCtD
Fluvoxamine—Sweating—Epirubicin—sarcoma	0.000144	0.000602	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—sarcoma	0.000144	0.000602	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—sarcoma	0.000143	0.000599	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000143	0.000595	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—sarcoma	0.000142	0.000594	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—sarcoma	0.000142	0.000593	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—sarcoma	0.000142	0.000592	CcSEcCtD
Fluvoxamine—Nausea—Thiotepa—sarcoma	0.000142	0.000591	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—sarcoma	0.000141	0.00059	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—sarcoma	0.000141	0.000589	CcSEcCtD
Fluvoxamine—Feeling abnormal—Etoposide—sarcoma	0.000141	0.000589	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—sarcoma	0.000141	0.000588	CcSEcCtD
Fluvoxamine—Diarrhoea—Mitoxantrone—sarcoma	0.000141	0.000588	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—sarcoma	0.000141	0.000587	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—sarcoma	0.00014	0.000586	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—sarcoma	0.00014	0.000585	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Etoposide—sarcoma	0.00014	0.000584	CcSEcCtD
Fluvoxamine—Dizziness—Vincristine—sarcoma	0.00014	0.000583	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—sarcoma	0.000139	0.000581	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000138	0.000576	CcSEcCtD
Fluvoxamine—Bradycardia—Epirubicin—sarcoma	0.000138	0.000574	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—sarcoma	0.000137	0.000571	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000136	0.00057	CcSEcCtD
Fluvoxamine—Urticaria—Etoposide—sarcoma	0.000136	0.000568	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—sarcoma	0.000136	0.000567	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—sarcoma	0.000136	0.000566	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—sarcoma	0.000136	0.000566	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—sarcoma	0.000135	0.000565	CcSEcCtD
Fluvoxamine—Abdominal pain—Etoposide—sarcoma	0.000135	0.000565	CcSEcCtD
Fluvoxamine—Body temperature increased—Etoposide—sarcoma	0.000135	0.000565	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—sarcoma	0.000135	0.000565	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—sarcoma	0.000135	0.000565	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—sarcoma	0.000135	0.000564	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—sarcoma	0.000135	0.000564	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—sarcoma	0.000134	0.000561	CcSEcCtD
Fluvoxamine—Vomiting—Vincristine—sarcoma	0.000134	0.000561	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—sarcoma	0.000134	0.00056	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—sarcoma	0.000133	0.000557	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—sarcoma	0.000133	0.000557	CcSEcCtD
Fluvoxamine—Rash—Vincristine—sarcoma	0.000133	0.000556	CcSEcCtD
Fluvoxamine—Dermatitis—Vincristine—sarcoma	0.000133	0.000556	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—sarcoma	0.000133	0.000555	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—sarcoma	0.000133	0.000554	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—sarcoma	0.000132	0.000553	CcSEcCtD
Fluvoxamine—Headache—Vincristine—sarcoma	0.000132	0.000553	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000132	0.00055	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—sarcoma	0.000131	0.000548	CcSEcCtD
Fluvoxamine—Vomiting—Mitoxantrone—sarcoma	0.000131	0.000546	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—sarcoma	0.000131	0.000545	CcSEcCtD
Fluvoxamine—Visual impairment—Epirubicin—sarcoma	0.00013	0.000543	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—sarcoma	0.00013	0.000542	CcSEcCtD
Fluvoxamine—Rash—Mitoxantrone—sarcoma	0.00013	0.000542	CcSEcCtD
Fluvoxamine—Dermatitis—Mitoxantrone—sarcoma	0.00013	0.000541	CcSEcCtD
Fluvoxamine—Headache—Mitoxantrone—sarcoma	0.000129	0.000538	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—sarcoma	0.000128	0.000533	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—sarcoma	0.000127	0.000531	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—sarcoma	0.000126	0.000527	CcSEcCtD
Fluvoxamine—Hypersensitivity—Etoposide—sarcoma	0.000126	0.000527	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—sarcoma	0.000126	0.000526	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—sarcoma	0.000126	0.000524	CcSEcCtD
Fluvoxamine—Nausea—Vincristine—sarcoma	0.000126	0.000524	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—sarcoma	0.000125	0.000523	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—sarcoma	0.000125	0.000523	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—sarcoma	0.000125	0.000522	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—sarcoma	0.000125	0.000522	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—sarcoma	0.000124	0.000519	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—sarcoma	0.000124	0.000518	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—sarcoma	0.000123	0.000515	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—sarcoma	0.000123	0.000514	CcSEcCtD
Fluvoxamine—Asthenia—Etoposide—sarcoma	0.000123	0.000513	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—sarcoma	0.000123	0.000512	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—sarcoma	0.000123	0.000511	CcSEcCtD
Fluvoxamine—Nausea—Mitoxantrone—sarcoma	0.000122	0.00051	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—sarcoma	0.000121	0.000506	CcSEcCtD
Fluvoxamine—Pruritus—Etoposide—sarcoma	0.000121	0.000506	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—sarcoma	0.000121	0.000504	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—sarcoma	0.00012	0.000503	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—sarcoma	0.000119	0.000498	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—sarcoma	0.000118	0.000494	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—sarcoma	0.000118	0.000493	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—sarcoma	0.000118	0.000491	CcSEcCtD
Fluvoxamine—Diarrhoea—Etoposide—sarcoma	0.000117	0.000489	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—sarcoma	0.000117	0.000488	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—sarcoma	0.000117	0.000486	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—sarcoma	0.000116	0.000484	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—sarcoma	0.000116	0.000484	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—sarcoma	0.000115	0.000482	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—sarcoma	0.000115	0.000481	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—sarcoma	0.000114	0.000477	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—sarcoma	0.000114	0.000475	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—sarcoma	0.000113	0.000473	CcSEcCtD
Fluvoxamine—Dizziness—Etoposide—sarcoma	0.000113	0.000473	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—sarcoma	0.000113	0.000472	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—sarcoma	0.000112	0.000468	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—sarcoma	0.000112	0.000466	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—sarcoma	0.000111	0.000463	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—sarcoma	0.00011	0.000461	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—sarcoma	0.000109	0.000457	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—sarcoma	0.000109	0.000455	CcSEcCtD
Fluvoxamine—Vomiting—Etoposide—sarcoma	0.000109	0.000454	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—sarcoma	0.000109	0.000454	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—sarcoma	0.000109	0.000454	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—sarcoma	0.000108	0.000451	CcSEcCtD
Fluvoxamine—Rash—Etoposide—sarcoma	0.000108	0.000451	CcSEcCtD
Fluvoxamine—Dermatitis—Etoposide—sarcoma	0.000108	0.00045	CcSEcCtD
Fluvoxamine—Headache—Etoposide—sarcoma	0.000107	0.000448	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—sarcoma	0.000107	0.000448	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—sarcoma	0.000107	0.000446	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—sarcoma	0.000107	0.000445	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—sarcoma	0.000106	0.000443	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—sarcoma	0.000106	0.000441	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—sarcoma	0.000106	0.000441	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—sarcoma	0.000105	0.00044	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—sarcoma	0.000105	0.000439	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—sarcoma	0.000105	0.000439	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—sarcoma	0.000105	0.000437	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—sarcoma	0.000104	0.000434	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—sarcoma	0.000103	0.000431	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—sarcoma	0.000103	0.000428	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—sarcoma	0.000103	0.000428	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—sarcoma	0.000102	0.000425	CcSEcCtD
Fluvoxamine—Nausea—Etoposide—sarcoma	0.000102	0.000424	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—sarcoma	0.000102	0.000424	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—sarcoma	0.000101	0.000421	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—sarcoma	0.000101	0.00042	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—sarcoma	0.0001	0.000418	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—sarcoma	0.0001	0.000418	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—sarcoma	0.0001	0.000418	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—sarcoma	0.0001	0.000417	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—sarcoma	9.98e-05	0.000416	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—sarcoma	9.89e-05	0.000413	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—sarcoma	9.81e-05	0.00041	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—sarcoma	9.79e-05	0.000409	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—sarcoma	9.78e-05	0.000408	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—sarcoma	9.76e-05	0.000407	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—sarcoma	9.74e-05	0.000407	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—sarcoma	9.68e-05	0.000404	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—sarcoma	9.61e-05	0.000401	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—sarcoma	9.6e-05	0.000401	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—sarcoma	9.6e-05	0.000401	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—sarcoma	9.56e-05	0.000399	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—sarcoma	9.53e-05	0.000398	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—sarcoma	9.49e-05	0.000396	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—sarcoma	9.44e-05	0.000394	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—sarcoma	9.43e-05	0.000394	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—sarcoma	9.41e-05	0.000393	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—sarcoma	9.4e-05	0.000392	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—sarcoma	9.39e-05	0.000392	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—sarcoma	9.37e-05	0.000391	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—sarcoma	9.28e-05	0.000387	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—sarcoma	9.26e-05	0.000387	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—sarcoma	9.26e-05	0.000387	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—sarcoma	9.26e-05	0.000387	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—sarcoma	9.23e-05	0.000385	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—sarcoma	9.15e-05	0.000382	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—sarcoma	9.15e-05	0.000382	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—sarcoma	9.06e-05	0.000378	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—sarcoma	8.97e-05	0.000374	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—sarcoma	8.95e-05	0.000374	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—sarcoma	8.88e-05	0.000371	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—sarcoma	8.88e-05	0.000371	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—sarcoma	8.82e-05	0.000368	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—sarcoma	8.74e-05	0.000365	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—sarcoma	8.74e-05	0.000365	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—sarcoma	8.71e-05	0.000364	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—sarcoma	8.69e-05	0.000363	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—sarcoma	8.68e-05	0.000362	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—sarcoma	8.67e-05	0.000362	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—sarcoma	8.62e-05	0.00036	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—sarcoma	8.58e-05	0.000358	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—sarcoma	8.56e-05	0.000357	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—sarcoma	8.53e-05	0.000356	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—sarcoma	8.46e-05	0.000353	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—sarcoma	8.45e-05	0.000353	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—sarcoma	8.34e-05	0.000348	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—sarcoma	8.3e-05	0.000346	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—sarcoma	8.29e-05	0.000346	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—sarcoma	8.27e-05	0.000345	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—sarcoma	8.21e-05	0.000343	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—sarcoma	8.21e-05	0.000343	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—sarcoma	8.09e-05	0.000338	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—sarcoma	8.03e-05	0.000335	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—sarcoma	7.97e-05	0.000333	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—sarcoma	7.92e-05	0.00033	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—sarcoma	7.91e-05	0.00033	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—sarcoma	7.89e-05	0.00033	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—sarcoma	7.85e-05	0.000328	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—sarcoma	7.82e-05	0.000326	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—sarcoma	7.72e-05	0.000322	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—sarcoma	7.67e-05	0.00032	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—sarcoma	7.66e-05	0.00032	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—sarcoma	7.62e-05	0.000318	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—sarcoma	7.59e-05	0.000317	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—sarcoma	7.59e-05	0.000317	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—sarcoma	7.59e-05	0.000317	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—sarcoma	7.59e-05	0.000317	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—sarcoma	7.32e-05	0.000305	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—sarcoma	7.26e-05	0.000303	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—sarcoma	7.07e-05	0.000295	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—sarcoma	7.05e-05	0.000294	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—sarcoma	7.02e-05	0.000293	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—sarcoma	7.02e-05	0.000293	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—sarcoma	6.89e-05	0.000287	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—sarcoma	6.79e-05	0.000283	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—sarcoma	6.57e-05	0.000274	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—sarcoma	6.54e-05	0.000273	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—sarcoma	6.37e-05	0.000266	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—sarcoma	6.35e-05	0.000265	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—sarcoma	6.28e-05	0.000262	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—sarcoma	6.1e-05	0.000255	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—sarcoma	6.08e-05	0.000254	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—sarcoma	6.05e-05	0.000253	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—sarcoma	6.05e-05	0.000252	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—sarcoma	6.01e-05	0.000251	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—sarcoma	5.87e-05	0.000245	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—sarcoma	5.7e-05	0.000238	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—sarcoma	5.65e-05	0.000236	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—sarcoma	5.6e-05	0.000234	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—sarcoma	5.59e-05	0.000233	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—sarcoma	5.56e-05	0.000232	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—sarcoma	5.27e-05	0.00022	CcSEcCtD
